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1.1. Document Development Process
The Society of Pediatric Cardiology Training Program
Directors (SPCTPD) board assembled a Steering Com-
mittee that nominated 2 chairs, 1 SPCTPD Steering
Committee member, and 4 additional experts from
a wide range of program sizes, geographic regions,
and subspecialty focuses. Representatives from the
American College of Cardiology (ACC), American
Academy of Pediatrics (AAP), and American Heart
Association (AHA) participated. The Steering Com-
mittee member was added to provide perspective to
each Task Force as a “nonexpert” in that ﬁeld.
Relationships with industry and other entities were
not deemed relevant to the creation of a general
cardiology training statement; however, employment
and afﬁliation information for authors and peer
reviewers are provided in Appendixes 1 and 2, respec-
tively, along with disclosure reporting categories.,
t
,
-
-
l
,
-
/Comprehensive disclosure information for all authors,
including relationships with industry and other en-
tities, is available as an online supplement to this
document.
The writing committee developed the document,
approved it for review by individuals selected by
the participating organizations (Appendix 2), and
addressed their comments. The ﬁnal document was
approved by the SPCTPD, AAP, and AHA in February
2015 and approved by the ACC in March 2015. This
document is considered current until the SPCTPD
revises or withdraws it.
1.2. Background and Scope
It is estimated that there are currently more adults
than children with congenital heart disease (CHD).
Despite this, most adult cardiologists are not familiar
with CHD, and to date, pediatric cardiology training
has not focused on typical adult diseases or on the
social issues that impact adults. Pediatric cardiology
training will provide a sound basis for the diagnosis
and management of CHD that spans all ages; however,
the manifestations, diagnosis, treatments, and out-
comes of CHD in adults have important differences
from those diseases in children.
The goal of Adult Congenital Heart Disease (ACHD)
training for pediatric cardiology fellows is to expose
them to the common sequelae of both repaired and
unrepaired CHD in the adult. This presupposes that
the trainee has a solid foundation in the principles of
CHD diagnosis and management gained through his or
her pediatric cardiology training. Additional subjects
for trainees to learn should include the common
medical conditions encountered in adults such as
coronary disease, pregnancy, and depression. The
impact of issues such as employment and insurability
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impact patient well-being.
A smooth transition of patients from pediatric to adult
care is the ﬁrst step in ACHD care, and in most medical
systems, that responsibility lies with the pediatric pro-
viders. Therefore, education on the transition process,
awareness of the needs of ACHD patients, systems avail-
able for care of ACHD patients, and resources to ensure
adequate cardiac care are all important parts of the pe-
diatric cardiology curriculum in ACHD.
There are a variety of ways to fulﬁll the training goals
in ACHD. The ideal experience combines didactic lectures
and dedicated inpatient and outpatient ACHD clinical
rotations. There is substantial variation between in-
stitutions in the care of ACHD patients, and pediatric
cardiology fellowship training programs should avail
themselves of dedicated ACHD-trained or experienced
cardiologists and ACHD programs. For those fellows
desiring to care for ACHD patients, additional subspe-
cialty training is required that is more intensive and
focused than the ACHD training in either pediatric or
adult cardiology programs. What follows are descriptions
of the different issues that should be addressed in core
ACHD training for pediatric cardiology fellows. For those
who desire to pursue a career as an ACHD specialist, 2 years
of additional training will be needed to fulﬁll the re-
quirements for the ACHD Board Certiﬁcation examination.
Our revised training recommendations describe the
program resources and environment that are required
for training pediatric cardiology fellows, together with a
competency-based system promulgated by the American
College of Graduate Medical Education (ACGME), to
implement speciﬁc goals and objectives for training
pediatric cardiology fellows. This system categorizes
competencies into 6 core competency domains: Medi-
cal Knowledge, Patient Care and Procedural Skills,
Systems-Based Practice, Practice-Based Learning and
Improvement, Professionalism, and Interpersonal and
Communication Skills, along with identiﬁcation of sug-
gested evaluation tools for each domain. Core compe-
tencies unique to ACHD are covered in Section 3 (see
the “2015 SPCTPD/ACC/AAP/AHA Training Guidelines
for Pediatric Cardiology Fellowship Programs [Revision of
the 2005 Training Guidelines for Pediatric Cardiology
Fellowship Programs]: Introduction” for additional com-
petencies that apply to all Task Force reports).
1.3. Levels of Expertise—Core and Advanced
In this statement, we discuss core training for all fellows
enrolled in a traditional 3-year pediatric cardiology
fellowship and advanced training for fellows who wish to
embark on a career in ACHD. Core training is required for
all trainees and is intended to ensure that fellows acquire
the knowledge base and skills necessary to become apediatric cardiologist referring his/her patient at an age
appropriate for ACHD care. Advanced training guidelines
are recommended for fellows who wish to specialize in
ACHD following training. In December 2012, after a joint
petition by the American Board of Pediatrics and Amer-
ican Board of Internal Medicine, ACHD was formally
recognized by the American Board of Medical Specialties
as a subspecialty of adult and pediatric cardiology. As
such, advanced training is needed to qualify a fellow to
sit for the ACHD Board examination and to be an ACHD
cardiologist. Advanced ACHD training is for an additional
2 years after completion of either pediatric cardiology or
adult cardiovascular disease training. The speciﬁcs of the
ACHD training pathways are being developed and are
part of the 2015 adult cardiology training guidelines (1).
2. PROGRAM RESOURCES AND ENVIRONMENT
Training in ACHD should be obtained in a center or cen-
ters where there is both a pediatric and an adult cardiol-
ogy training program accredited by the ACGME. Ideally,
the training center has available ACHD expertise from at
least 1 trained or experienced ACHD cardiologist, multi-
disciplinary ACHD experience, and a dedicated ACHD
program or clinic. This center should have clinical vol-
umes sufﬁcient to allow for exposure of each trainee to
a wide spectrum of ACHD. If the training center lacks
ACHD expertise, consideration for “away rotations” and
electronic educational resources to ensure attainment of
training requirements should be considered.
Pediatric cardiology trainees should be aware of the
2008 ACC/AHA guidelines (2) regarding care of patients in
ACHD centers. This may involve routine primary cardiol-
ogy care at the ACHD center or shared care with a local
referring cardiologist. The type and location of care rec-
ommended depends on the severity and complexity of the
underlying condition. The 32nd Bethesda conference (3)
outlines the components of a comprehensive regional
ACHD referral center. It is recommended that non-ACHD
adult or pediatric cardiologists caring for adults develop
a referral relationship with an established center.
At a core competency level, there are several mecha-
nisms that would fulﬁll the training goals in ACHD. The
exposure to dedicated ACHD care should occur early
within the pediatric cardiology fellowship, ideally within
the ﬁrst year of training. For many programs, a dedicated
1-month rotation with an established ACHD program is
preferred. The rotation would allow a spectrum of expo-
sure to ACHD patients, including outpatient clinic, inpa-
tient consults, imaging, and exposure to the array of
issues ACHD patients may face, including CHD-related
cardiac issues, non-CHD cardiac issues (i.e., coronary
disease), cardiac and noncardiac surgery, heart failure,
pulmonary hypertension, and obstetrics. If there are no
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725dedicated local ACHD programs, then local hospital-based
graduate medical education (GME) should provide sup-
port for an away elective. With over 100 established ACHD
programs throughout the country, most pediatric cardi-
ology fellowship programs are in coordination with an
ACHD program or a program exists within close prox-
imity. However, if there are no local ACHD programs or an
away-elective is not feasible for various reasons, online
modules should be utilized as part of the requirements for
pediatric cardiology fellows. Many sources exist for this
information, and program directors must be familiar with
the various online learning opportunities to create the best
possible learning experience for their pediatric cardiology
trainees if a dedicated ACHD rotation is not feasible.
Trainees should be familiar with the multiple environ-
ments in which ACHD patients are followed for both inpa-
tient care (adult hospitals, children’s hospitals, and
combined hospitals) and outpatient care (pediatric cardi-
ology, general adult cardiology, and ACHD cardiology).
They should also recognize that many patients are “lost” or
neglect follow-up and may be seen only in general practice
environments such as family or internal medicine or may
receive no medical care at all unless emergencies arise. It
is common for ACHD patients to present to an emergency
room with little knowledge of their heart condition, prior
surgeries and interventions, or even their medications.
It is important for fellows to understand when to refer
ACHD patients for noncongenital adult medical expertise
(cardiac and noncardiac), including the ﬁelds of general
internal medicine, obstetrics, gynecology, nephrology,
hepatology, hematology, and psychiatry. Speciﬁc expo-
sure to multidisciplinary teams caring for ACHD should
be emphasized, including those outlined in Table 1.
Any diagnostic or interventional procedures for adults
with moderate or complex CHD including (but not limited
to) catheterization, surgery, echocardiography, or cardiac
magnetic resonance imaging (MRI) should be performed
in a location and by personnel with expertise in that
modality and ACHD. For procedures requiring anesthesia,TABLE 1 Multidisciplinary Teams Involved in ACHD Care
n High-risk obstetrics
n Pulmonary hypertension
n Heart failure/transplant
n Genetics
n Neurology
n Nephrology
n Hematology
n Gastroenterology
n Cardiac pathology
n Rehabilitation services
n Social services
n Vocational services
n Financial counselors
Adapted from the 2008 ACC/AHA Guidelines for the Management of Adults With
Congenital Heart Disease (2).
ACC indicates American College of Cardiology; ACHD, adult congenital heart disease;
and AHA, American Heart Association.it is important to include cardiac anesthesiologists with
experience with ACHD.
3. CORE TRAINING: GOALS AND METHODS
Trainees will be expected to develop an appropriate level
of knowledge and experience in the following areas.
3.1. Managing the Transition From Adolescence to Adulthood
Transitioning the care of the adolescent to adulthood
should begin with encouraging greater patient involve-
ment in their health care. Emphasis should be placed
on uninterrupted health care that is patient centered,
age and developmentally appropriate, ﬂexible, and
comprehensive. Age-appropriate education about medi-
cal conditions should promote skills in communication,
decision making, self-care, and self-advocacy. This will
promote greater personal and medical independence and
a sense of control over healthcare decisions. The ultimate
goal of a transition program is to optimize the quality of
life, life expectancy, and future productivity of young
patients (2). Speciﬁc teaching goals include learning:
n The concept of comprehensive care that is coordinated
and managed through a medical home
n The need to educate adult providers in managing
chronic conditions previously limited to the pediatric
population
n The need for ongoing, coordinated communication
between patients, families, and pediatric and adult
healthcare providers to facilitate transition and transfer
n The timing for transition, which should be based on
the patient’s medical and development status and
should be individualized to both the patient and
family’s needs
n The need to engage the adolescent in transition plan-
ning, raising awareness in the early teenage years
n The need for the pediatric cardiology provider to
initiate and work together with the adolescent and
family on a transition plan
n The importance of pediatric providers directing health
discussions toward the adolescent in a way that is
developmentally appropriate and sensitive to parental
concerns
3.2. Recognition of Concomitant Adult Medical Conditions
Adults with CHD may develop comorbidities that can
either complicate the management of CHD or worsen the
outcomes of CHD. The care of adults with CHD requires
familiarity with common adult medical conditions, both
cardiac and noncardiac, and awareness of available
guidelines to treat them. Important conditions in-
clude coronary artery disease, acute myocardial infarc-
tion, heart failure, hypertension, hyperlipidemia, atrial
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726ﬁbrillation, stroke, diabetes mellitus, metabolic syn-
drome, sleep apnea, obstructive lung disease, obesity,
lifestyle issues, including tobacco, alcohol, and drug use;
exercise; and depression/anxiety.
Familiarity with the commonly used medical therapies
for adult-acquired heart disease is needed, including
statins, aspirin, beta blockers, angiotensin-converting
enzyme inhibitors/angiotensin receptor blockers, aldo-
sterone antagonists, and anticoagulants. Trainees must
also learn the difference in accepted indications for
pediatric and adult patients for these medications.
Pediatric cardiologists are not expected to manage
uniquely adult cardiac or noncardiac conditions, but need
to be aware of available resources for appropriate inter-
nist, cardiologist, or other subspecialty referrals.
3.3. Knowledge of Electrophysiology in ACHD Care
Arrhythmias are common in ACHD patients, and effective
diagnosis and management requires understanding of
the underlying anatomy, surgical repairs, and treatment
options (4). Although there are many similarities in the
diagnosis and management of arrhythmias in ACHD pa-
tients compared to pediatric patients, the presentation,
complications, management options, and outcomes may
be quite different. There are subgroups of ACHD in whom
the risk for arrhythmias increases with age such as
Mustard/Senning repairs of transposition of the great
arteries (TGA) and atriopulmonary Fontan palliations.
These patients are prone to both tachyarrhythmias and
bradyarrhythmias; therefore, a thorough understanding
of these operations is essential.
Anticoagulation for stroke prevention may differ in
ACHD patients because of advancing age and comorbid-
ities. Management may be helped by the ACC/AHA
guidelines regarding stroke prevention in the presence of
atrial arrhythmias (5).
3.4. Management of Advanced Heart Failure and Determination
of Transplant Candidacy in ACHD Patients
As the population of adults with CHD continues to in-
crease, so does the prevalence of heart failure. Pediatric
cardiology fellowship training should include an under-
standing of the multiple factors that contribute to ven-
tricular dysfunction in adults with CHD (6,7), including
abnormal vascular function, particularly in those with
Fontan physiology (8,9).
Training should emphasize ACHD patients who are at
signiﬁcant risk of heart failure, particularly those with
systemic right ventricles, including Mustard/Senning re-
pairs of TGA and congenitally corrected TGA, as well as
patients with a single ventricle who have undergone a
Fontan procedure (10). They should also understand the
neurohormonal abnormalities that frequently accompany
heart failure in these adults (11).Each fellow should have an understanding of the
currently available options for mechanical circulatory
support (MCS) in adult congenital heart patients (12)
and participate in multidisciplinary team discussions
regarding optimal timing of referral of adults with CHD for
MCS/transplant (13). Fellows should also understand the
potential difﬁculties or contraindications of transplant in
adults. This may range, for example, from issues of
alloimmunization to technical limitations, pulmonary
hypertension, and substance use.
3.5. Understanding the Unique Aspects of Caring for
Cyanotic Adults With Eisenmenger Syndrome and
Pulmonary Vascular Disease
A subset of ACHD patients live with cyanosis, either from
unrepaired or palliated CHD or reversal of a left-to-right
shunt due to Eisenmenger syndrome (ES). These adults
may present with multisystem dysfunction from the sec-
ondary erythrocytosis that occurs as a result of their
hypoxemia. Fellows need to recognize these complica-
tions, which include iron deﬁciency, gallstones, gout, and
cerebral vascular accidents. They also should know the
therapies to prevent these complications (e.g., avoidance
of dehydration, iron replacement) (14). ACHD patients
may also experience pulmonary vascular disease. In 1
large population-based study, the prevalence of pulmo-
nary hypertension in ACHD patients was at least 6%, and
those patients had a more than 2-fold higher risk of all-
cause mortality and 3-fold higher risk of heart failure
and arrhythmias compared to those without pulmonary
hypertension (15). The trainee should be aware of recent
investigations of advanced therapies for pulmonary
vascular disease in ACHD patients that have offered
promise for improved quality of life and survival (16).
Despite guideline recommendations to treat adults with
ES with pulmonary vasodilator therapy (Class IIa, Level
of Evidence: C) (2), the majority of patients living with
ES are not receiving advanced therapies (17).
3.6. Recognition of the Importance of Palliative Care
Although the prognosis for many adults with CHD is quite
good with appropriate management, there are many pa-
tients who will die of their underlying CHD. For many pa-
tients with end-stage disease, there are surgical, medical,
or advanced heart failure therapies such as ventricular
assist devices or transplantation that can improve symp-
toms or longevity. However, many patients may not real-
istically beneﬁt from further aggressive treatment or may
choose not to continue therapy. If so, palliative caremay be
an appropriate option. The difﬁculty in providing accurate
prognostic data for ACHD patients can make the optimal
timing for palliative care referrals difﬁcult. There are
prognostic indicators in adults with heart failure as a result
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727of other causes that may also apply to ACHD patients, and
fellows should be familiar with these resources.
3.7. Understanding Mental Health and Cognitive Outcomes
The trainees need to be aware of the potential for neuro-
cognitive and psychological issues in ACHD patients. For
example, there is at least a 3 times higher prevalence of
psychiatric disorders, particularly depression and anxiety,
among adults with neurocognitive delays (18). There is
equivocal data on health-related quality of life in ACHD
patients compared to the general population depending
on the mode of evaluation. Some genetic syndromes, such
as 22q11 deletion, include a component of developmental
delay and the potential for adult-onset psychiatric disor-
ders (19). At this time, screening for depression, anxiety,
and other mood disorders is not in the ACHD guidelines,
but it is recommended that ACHD care providers be aware
of these issues and intervene or refer when appropriate.
It is also important for trainees to recognize the impact
that neurocognitive delay and impaired social adjust-
ments may have on future lifestyle issues in adulthood.
This is particularly true for assuming independence, dis-
ease self-management, and employment. Appropriate
counseling, particularly on employment options, should
be considered.
3.8. Assess Safety of Participation in Sports and Exercise
The most common congenital or inherited heart condi-
tions that have been associated with sudden death during
sports and exercise participation are hypertrophic car-
diomyopathy, coronary artery anomalies, Marfan syn-
drome, and aortic valve disease. Less common lesions
with increased risks are complex defects, such as repaired
transposition and single ventricle, and those with asso-
ciated pulmonary vascular disease. In addition, sudden
death may occur with arrhythmias induced by exercise
from certain forms of congenital long QT syndrome. As
adolescents and young adults enroll in progressively
more demanding activities, comprehensive evaluation
and counseling are essential. The goal should be to assess
the safety of participation in sports and exercise to opti-
mize quality of life and improve health. Trainees should
be familiar with the appropriate diagnostic testing needed
and the speciﬁc recommendations described within the
36th Bethesda Conference report (20). Equally important
is providing support, alternatives, and counseling for
those ACHD patients who are no longer able to participate
in sports they may have enjoyed in the past because of the
health risks they pose.
3.9. Recognition of Women’s Reproductive Health:
Contraception and Pregnancy
Over the course of training in pediatric cardiology, fellows
must learn the hemodynamic changes that occur duringpregnancy and the postpartum period. Each fellow should
demonstrate knowledge of the pregnancy-related physi-
ological changes in women with various types of CHD
during pregnancy and their potential consequences on
both the mother and fetus (21). They also need to know
the established risk factors for pregnant women with CHD
for both maternal cardiac and obstetrical complications
(22–24), genetic risks of recurrence of CHD in the fetus, as
well as late adverse cardiac outcomes (25). Each fellow
should obtain experience in counseling young women of
childbearing age with CHD regarding these potential risks.
Fellows should understand the hematologic changes
that occur during pregnancy and develop appropriate
therapeutic strategies for women with heart disease
requiring anticoagulation during pregnancy (26). They
should be educated regarding appropriate contraceptive
choices in young patients with CHD and provide coun-
seling regarding contraceptive choices (27,28). Each
fellow should get exposure to the multidisciplinary team
with the maternal–fetal medicine group to care for preg-
nant young women with CHD. Additionally, pediatric
cardiology fellows should be educated in the acute care
management of cardiac issues that can arise (i.e., hyper-
tension, arrhythmias) during pregnancy in women with
underlying CHD (21).
3.10. Assessment of Sexual Function
Among patients with cardiovascular disease, sexual
problems are highly prevalent in both men and women,
and have been shown to adversely affect the patients’
quality of life and well-being (29). To date, the discussion
of sexual dysfunction in adults with CHD is often
neglected. Recent studies have described an increased
prevalence of erectile dysfunction (30), decreased sexual
esteem, and/or distress with sex in adults with CHD (31).
Therefore, it is important for fellows to understand the
complex relationship between cardiovascular disease,
erectile dysfunction, and endothelial dysfunction (32).
Endothelial dysfunction is not only an important process
in the development of atherosclerotic cardiovascular
disease, but also plays a role in the pathophysiologic
mechanisms that contribute to erectile dysfunction. Sex-
ual activity is reasonable in most adult congenital pa-
tients who do not have decompensated heart failure,
severe valvular disease, or uncontrolled arrhythmias
(Class IIa, Level of Evidence: C) (33).
3.11. Knowledge of the Legislative Aspects of
Employment and Advocacy
Key aspects of providing quality of care for the adult with
CHD include addressing not only late medical and surgical
complications, but also the numerous social and psy-
chological adjustments that affect day-to-day life. This
includes vocational planning that should begin in
TABLE 2 Core Curricular Competencies and Evaluation Tools for ACHD
Medical Knowledge
n Know the unique aspects of caring for cyanotic adults, including Eisenmenger syndrome and pulmonary vascular disease.
n Know the electrophysiological abnormalities speciﬁc to ACHD patients.
n Know the mental health and cognitive outcomes in ACHD patients.
n Know the complex relationship between cardiovascular disease, erectile dysfunction, and endothelial dysfunction.
Evaluation Tools: direct observation, conference participation and presentation, and in-training examination
Patient Care and Procedural Skill
n Have the skills to manage the transition from adolescence to adulthood care of congenital heart disease.
n Have the skills to recognize concomitant adult medical conditions in ACHD patients.
n Have the skills to manage advanced heart failure and determine transplant candidacy in ACHD patients.
n Have the skills to initiate palliative care when appropriate.
n Have the skills to assess safety for ACHD patients to participate in sports and exercise.
n Have the skills to manage reproductive health issues in women with ACHD (i.e., contraception and pregnancy).
Evaluation Tools: direct observation, conference participation, in-training examination, and procedure logs
Systems-Based Practice
n Know the legislative aspects of employment and advocacy in ACHD patients.
Evaluation Tools: direct observation, conference participation, and in-training examination
ACHD indicates adult congenital heart disease.
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728adolescence so that appropriate educational options have
been established long before the patient enters the work
force (34). Although reports of employment status vary
with CHD, no more than 10% are considered totally
disabled (35). As many adults with CHD prepare to enter
the job market and establish a career (36), careful
consideration of both physical and psychological capa-
bilities should be discussed with their cardiologist so
that realistic employment options are explored. Crossland
et al. (37) demonstrated that structured career and em-
ployment advice has been shown to be associated with a
higher rate of employment (73%) than no such counseling
(46%). Therefore, a review of the AHA published guide-
lines “Recreational and Occupational Recommendations
for Young Patients With Heart Disease” (38) with patients
with CHD and their parents should be performed to
objectively assist with occupational counseling.
Knowledge of the legislative aspects of employment
and advocacy may not be routine in the outpatient
assessment in the adult with complex CHD. However,
keys to overcoming these barriers include the develop-
ment of educational materials or handouts to help ado-
lescents and young adult patients as they approach the
job market that focus on legal rights and tips for job
success and where to go for job training and/or vocational
counseling. The involvement of an adult congenitalTABLE 3
Advanced Training in Adult Congenital Heart Disease:
Pediatric Cardiology Training Background
n Participate in a regular outpatient clinic organized to care for adults with con
10 clinic patients per week, ideally at least 1 clinic per week, although more m
n Experience a range of diagnostic and therapeutic methods used in the care of
resonance imaging, computed tomography, diagnostic catheterization, and ex
n Participate in the perioperative evaluation of adults with CHD for both cardia
n Participate in outpatient evaluation and inpatient management of pregnancy
n Participate in inpatient and outpatient management of adults with CHD and h
management of these patients, as well as exposure to discussion/implementati
n Participate in the diagnosis and management of the arrhythmic complications
n For those with training in pediatric cardiology, but not adult cardiology, parti
cardiac disease that affect adults with CHD. This can include inpatient and out
specialties.
CHD indicates congenital heart disease.medical social worker who is knowledgeable of state
programs is most helpful to optimize opportunities.
The core curricular competencies for pediatric transi-
tion to ACHD are summarized in Table 2, grouped by
ACGME core competency domain, and showing corre-
sponding evaluation tools.
4. ADVANCED TRAINING: GOALS AND METHODS
Advanced ACHD training requires an additional 2 years
after completion of either pediatric cardiology or adult
cardiovascular disease training. The speciﬁcs of the ACHD
training pathways are being developed and a summary of
the proposed requirements are listed in Table 3.
5. EVALUATION AND DOCUMENTATION OF
COMPETENCE
All training programs should include written goals and
objectives for each ACHD rotation, with performance
goals set according to the fellow’s level of training.
These will serve as the basis for formative feedback.
A copy of these goals and objectives should be supplied
and explained to the trainee at the onset of fellowship
training and reviewed at the beginning of each rotation.
Evaluation of fellows should be performed midway
through, and at the completion of, each rotation;Proposed Requirements Applicable to Trainees From a
genital heart disease. The trainee should be involved in the care of at least
ay be necessary.
adults with CHD, including direct experience in echocardiography, magnetic
ercise testing.
c and noncardiac procedures and observe operative repairs.
in women with CHD.
eart failure and/or pulmonary arteriolar hypertension. Participate in medical
on of mechanical circulatory support and transplant as options for treatment.
seen in adults with CHD, both medical therapy and interventional options.
cipate in the internal medicine rotations that focus on acquired medical and
patient general adult cardiology, heart failure/transplant, and noncardiology
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729evaluations should be directed toward whether the
fellow met those prespeciﬁed aims. The fellow evalua-
tion should be performed by the ACHD director and/or
senior ACHD physician. The fellow evaluation should
assess the fellow’s performance in each of the 6 areas
of core competencies, as appropriate for the level of
training, and should be based on direct observation of
the fellow. Evaluation of competency in preparation,
performance, and interpretation of the results of aprocedure should be given more consideration than
a focus on the number of procedures performed. Eval-
uation of competency should be done in person with
the trainee and documented in his or her fellowship
record. If the trainee is not progressing as expected,
remedial actions should be arranged and documented
in accordance with institutional procedures. All fel-
lows should maintain a log (preferably electronic) of all
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